These neurological vulnerabilities have made finding innovative ways to mitigate salt-induced damage a pressing public health priority. Now, a collaborative study conducted by researchers at Fujita Health University and industrial partners has shed light on a promising dietary candidate called LPC70. By analyzing its biochemical interactions, the research team has mapped out precisely how this soy-derived compound influences vital chemical signaling pathways in both the kidneys and the brain, offering a clearer picture of how nutrition might one day protect against the systemic damage caused by salty diets.
How a Soy Compound May Counter the Effects of Excess Salt
At the core of the new research are prostaglandins, a group of powerful lipid-derived signaling molecules synthesized from an essential fatty acid known as arachidonic acid. Operating much like localized hormones, prostaglandins play indispensable roles in regulating a wide array of physiological functions throughout the human body.
Within the cardiovascular system, these molecules act as crucial mediators of blood pressure by dynamically controlling the constriction and dilation of blood vessels. Their regulatory duties within the central nervous system, however, are significantly more complex. Depending entirely on which specific cellular receptors they engage, prostaglandin signals can either trigger protective mechanisms that safeguard delicate nerve cells or set off harmful cascades that impair memory, higher-level thinking, and emotional regulation.
The compound under investigation, LPC70, is a specialized form of soy lysolecithin where lysophosphatidylcholine accounts for more than 70 percent of the total phospholipid content. Although preceding laboratory experiments demonstrated that LPC70 could successfully alleviate salt-driven hypertension and associated cognitive deficits in animal models, the exact underlying molecular machinery remained elusive. Scientists particularly lacked an understanding of how the compound managed to modulate prostaglandin signaling pathways across different organ systems.
To bridge this critical knowledge gap, a dedicated research team led by Professor Akihiro Mouri and Dr. Hisayoshi Kubota, in close collaboration with Dr. Kazuhiro Kagotani, set out to observe the molecular impacts of LPC70 administration in mice subjected to a high-salt diet. Dr. Kubota, who served as the study’s first author, was instrumental in executing the experimental design. His methodical evaluation encompassed tracking blood pressure fluctuations, documenting behavioral modifications, and quantifying molecular activity tied directly to prostaglandin pathways. His hands-on work helped decipher how LPC70 exerts differential, protective effects across the diverse organs responsible for managing salt-induced cardiovascular and cognitive decline.
The institutional backing for the study bridges academia and industry. Prof. Mouri and Dr. Kubota conduct their research within the Department of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices at the Fujita Health University Graduate School of Medical Science, alongside their appointments at the International Center for Brain Science at Fujita Health University. Meanwhile, Dr. Kagotani brings an industry perspective to the collaboration, maintaining affiliations with Tsuji Oil Mills Co., Ltd. and the Tsuji Health and Beauty Science Laboratory at Mie University.
The findings resulting from this extensive collaboration were released online on May 14, 2026, and subsequently printed in Volume 197 of Neurochemistry International on July 1, 2026.
"We wanted to understand the role of LPC70 in coordinating changes in PG signaling across organ systems," noted Prof. Mouri, reflecting on the scope of the project. "Our study originated from a collaborative research project with Tsuji Oil Mills Co., Ltd, a company that develops naturally derived food ingredients," he added, highlighting the fruitful intersection of nutritional science and industry innovation.
Soy Compound Improves Blood Pressure and Memory in Mice
To test the efficacy of the compound, the researchers utilized a controlled animal model. As expected, mice maintained on a high-salt diet quickly developed elevated blood pressure, mirroring the primary systemic pathology observed in human populations consuming excessive sodium. However, the negative ramifications of the dietary intervention extended far beyond physical health metrics.
Behavioral testing revealed that the animals subjected to high salt levels also experienced marked psychological and cognitive shifts. They displayed a notable reduction in social interaction and struggled significantly to recognize familiar objects they had encountered previously, pointing toward explicit deficits in recognition memory. Intriguingly, other behavioral dimensions—such as general locomotor activity and anxiety-like tendencies—remained largely unaffected. This selective disruption indicates that excessive dietary salt does not cause a generalized, catastrophic impairment of the central nervous system; rather, it homes in on and specifically disrupts complex cognitive and social processing circuits.
When the research team supplemented the high-salt diet of these mice with LPC70, the trajectory of these health markers shifted dramatically. The animals experienced a measurable improvement in blood pressure regulation. Furthermore, when subjected to the same behavioral evaluations, the mice receiving the supplement performed noticeably better on tests measuring social engagement and object recognition memory, proving that the compound possessed tangible protective properties.
These encouraging phenotypic improvements served as a catalyst for a deeper biochemical investigation. The scientists sought to uncover the microscopic changes occurring within the renal systems and cerebral tissue of the treated animals to understand how LPC70 was achieving these protective feats.
Different Protective Effects in the Kidneys and Brain
Upon examining the renal tissue, the researchers discovered that a high-salt diet significantly upregulated the expression of two key molecular components involved in prostaglandin synthesis and signaling: cyclooxygenase-2, commonly known as COX-2, and the PGE2 receptor subtype EP3. Both of these biological factors are strongly implicated in driving the pathological elevation of blood pressure triggered by excessive sodium intake.
Remarkably, the introduction of LPC70 successfully suppressed these salt-induced elevations in the kidneys. This suggests that the compound helps normalize renal signaling pathways that would otherwise compromise the body’s ability to maintain healthy blood pressure parameters.
A fundamentally different, yet equally compelling, response was uncovered when the team analyzed the prefrontal cortex—a critical region of the brain responsible for higher-order thinking, memory formation, and social behavior. In animals maintained on excess salt without intervention, researchers observed a downregulation of the PGD2 receptor DP1, a protein heavily involved in orchestrating protective and anti-inflammatory signaling networks within the brain.
When LPC70 was administered, it successfully restored the expression levels of this vital neuroprotective receptor. Crucially, the compound achieved this without altering DP2, a secondary receptor associated with potentially deleterious and neuroinflammatory pathways. This nuanced selectivity is scientifically significant. It demonstrates that LPC70 does not act as a blunt instrument that indiscriminately upregulates or downregulates all prostaglandin activity across the body. Instead, it demonstrates a sophisticated pharmacological profile, selectively favoring signaling pathways that safeguard neural tissue, which likely accounts for the preservation of memory and social behaviors observed in the test subjects.
A Surprising Change in Chemical Signaling
Beyond tracking individual receptors, the research team stumbled upon an unexpected metabolic shift involving arachidonic acid, the foundational fatty acid utilized by biological systems to manufacture prostaglandins in the first place.
Biochemical assays revealed that mice subjected to a high-salt diet exhibited lower circulating levels of available arachidonic acid. Paradoxically, when these same salt-loaded mice were treated with LPC70, the levels of downstream prostaglandins derived from that fatty acid—including PGE2 and PGD2—actually increased.
This counterintuitive finding suggests that LPC70 does not simply flood the system with raw materials; rather, it appears to optimize the body’s metabolic efficiency, helping tissues make better use of the limited arachidonic acid available under high-salt conditions to synthesize necessary regulatory molecules.
When viewed as a whole, the data paints a picture of a coordinated yet highly adaptable physiological response. In the peripheral filtration systems of the kidneys, LPC70 acts to suppress signaling pathways tied directly to hypertension. Simultaneously, within the complex landscape of the brain, it restores signaling networks dedicated to mitigating inflammation and cellular damage. The therapeutic reach of the compound is thus defined by its contextual interaction with both the specific organ involved and the targeted prostaglandin receptors.
Could Soy-Based Ingredients Help Protect Against Excess Salt?
The implications of these findings suggest that LPC70 could eventually evolve into a valuable functional food ingredient, offering a dietary shield against some of the more pernicious health consequences tied to modern, sodium-heavy diets.
Its demonstrated capacity to concurrently improve blood pressure parameters and cognitive performance in experimental models raises the exciting prospect that similar interventions might eventually support cardiovascular and neurological health in human populations struggling with high dietary sodium intake. Nevertheless, researchers caution that these promising insights are derived entirely from preclinical animal studies. Translating these findings into tangible human health benefits will require rigorous, controlled clinical trials to confirm safety, efficacy, and appropriate dosing.
"Our study elucidates LPC70’s role in PG signaling, laying the groundwork for future clinical research and dietary interventions aimed at reducing hypertension-related cognitive decline and promoting healthy aging globally," concluded Prof. Mouri, summarizing the broader clinical vision of the work.
By illuminating the molecular mechanics through which a naturally occurring soy derivative interacts with the body’s stress response to sodium, the study opens new avenues for nutritional strategies aimed at preserving long-term cardiovascular and cognitive health.
The project received essential funding and institutional support from several key organizations, including Grants-in-Aid for Scientific Research provided by the Japan Society for the Promotion of Science under reference numbers 20K07931, 22K07606, 22K11891, and 23H02843. Additional financial backing was extended by the Fujita Mind-Brain Research & Innovation Center for Drug Generation through Japan’s Peak Research Universities Program, alongside the Japan Science and Technology Agency FOREST Program. Tsuji Oil Mills Co., Ltd. also provided direct financial support for the investigation, complemented by grants and resources from the Education and Research Facility of Animal Models for Human Diseases at Fujita Health University, the Smoking Research Foundation, and the Takeda Science Foundation.